Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nele Goeyvaerts

Showing results (21-30 of 22) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 22 results.
Antiviral Therapy|June 13, 2022
JNJ-73763989 pharmacokinetics and safety: Liver-targeted siRNAs against hepatitis B virus, in Japanese and non-Japanese healthy adults, and combined with JNJ-56136379 and a nucleos(t)ide analogue in patients with chronic hepatitis BEd Gane, Man-Fung Yuen, Thomas N Kakuda, et al.
The New England Journal of Medicine|November 26, 2025
Daily Mosnodenvir as Dengue Prophylaxis in a Controlled Human Infection ModelAnna P Durbin, Liesbeth Van Wesenbeeck, Kristen K Pierce, et al.
Pageof 3

Showing results (21-30 of 22) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 22 results.
Antiviral Therapy|June 13, 2022
JNJ-73763989 pharmacokinetics and safety: Liver-targeted siRNAs against hepatitis B virus, in Japanese and non-Japanese healthy adults, and combined with JNJ-56136379 and a nucleos(t)ide analogue in patients with chronic hepatitis BEd Gane, Man-Fung Yuen, Thomas N Kakuda, et al.
The New England Journal of Medicine|November 26, 2025
Daily Mosnodenvir as Dengue Prophylaxis in a Controlled Human Infection ModelAnna P Durbin, Liesbeth Van Wesenbeeck, Kristen K Pierce, et al.
Pageof 3